|
Wanxing Cui MD, PhD
Director, Cell Therapy Manufacturing Facility
MedStar Georgetown University
USA
|
Dr. Wanxing Cui is an accomplished scientist with extensive experience and expertise in the field of cell therapy. He has held the position of Director of the Cell Therapy Manufacturing Facility at MedStar Georgetown University Hospital since 2015, where he has demonstrated exceptional leadership in the development and production of cell-based therapies. Dr. Cui has published over 60 peer-reviewed scientific papers and is a member of various professional organizations, including the American Diabetes Association, the American Society of Transplantation, the Cell Transplantation Society, and the International Pancreas Islet Transplantation Association.
Dr. Cui is an active representative on the FACT Board of Directors for the International Society for Cellular Therapy, where he provides valuable insights and expertise on cell therapy regulation and accreditation. He is also a member of the Cellular Therapies Section Coordinating Committee at the Association for the Advancement of Blood & Biotherapies (AABB) and the iPSC Joint Committee and Lab Practice Committee at the International Society for Cell and Gene Therapy (ISCT). Dr. Cui's contributions to the field have been recognized with awards and honors, and he is highly respected by his colleagues and peers.
Dr. Cui is an editorial board member for the Journal Cytotherapy under the ISCT. He is also an active AABB assessor, an active CAP inspector, and a FACT cell therapy processing inspector for both minimal and more minimal manipulation. Dr. Cui's dedication to advancing the field of cell therapy is evident in his continued contributions to research, his active involvement in professional organizations, and his commitment to educating and training the next generation of scientists and healthcare professionals.
Dr. Cui is an active representative on the FACT Board of Directors for the International Society for Cellular Therapy, where he provides valuable insights and expertise on cell therapy regulation and accreditation. He is also a member of the Cellular Therapies Section Coordinating Committee at the Association for the Advancement of Blood & Biotherapies (AABB) and the iPSC Joint Committee and Lab Practice Committee at the International Society for Cell and Gene Therapy (ISCT). Dr. Cui's contributions to the field have been recognized with awards and honors, and he is highly respected by his colleagues and peers.
Dr. Cui is an editorial board member for the Journal Cytotherapy under the ISCT. He is also an active AABB assessor, an active CAP inspector, and a FACT cell therapy processing inspector for both minimal and more minimal manipulation. Dr. Cui's dedication to advancing the field of cell therapy is evident in his continued contributions to research, his active involvement in professional organizations, and his commitment to educating and training the next generation of scientists and healthcare professionals.